These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 13445101)

  • 1. [Systemic endangiitis obliterans; also a contribution to the pathogenesis of arteriosclerosis].
    ASANG E; MITTELMEIER H
    Arch Kreislaufforsch; 1957 Jun; 26(3):143-217. PubMed ID: 13445101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiology of endangiitis and arteriosclerosis obliterans].
    SCHRADER EA; WESTPHAL A
    Klin Wochenschr; 1951 Jan; 29(1-2):19-20. PubMed ID: 14825735
    [No Abstract]   [Full Text] [Related]  

  • 3. A surgeon's view of atherosclerosis.
    CREECH O
    Am Heart J; 1957 Nov; 54(5):641-2. PubMed ID: 13469732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endangiitis obliterans of the internal organs with special reference to endangiitis obliteran intestinalis].
    CARSTENSEN G
    Chirurg; 1958 Mar; 29(3):125-32. PubMed ID: 13537234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis obliterans in diabetes mellitus].
    Ito M; Nihei Z; Sugihara K
    Nihon Rinsho; 1997 Oct; 55 Suppl():772-6. PubMed ID: 9392195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiology, etiology, pathology, and pathophysiology of arteriosclerosis obliterans].
    Miyahara T; Shigematsu K
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():324-7. PubMed ID: 27266111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the risk factors in arteriosclerosis obliterans].
    Puchmayer V; Bazika V
    Cas Lek Cesk; 1974 Feb; 113(6):172-8. PubMed ID: 4434434
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of endangiitis obliterans in women].
    LAU H; HEINZEL J
    Chirurg; 1958 Feb; 29(2):68-70. PubMed ID: 13511580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arteriosclerosis obliterans-like vascular changes in diabetes mellitus].
    Kowalska M; Siciński A
    Pol Arch Med Wewn; 1966; 36(6):793-6. PubMed ID: 5911403
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathology of arteriosclerosis obliterans].
    Hosoda Y
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):471-5. PubMed ID: 8808806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis of endangiitis and arteriosclerosis obliterans].
    Krahl D; Preuss EG; Krahl R; Müller G
    Z Gesamte Inn Med; 1982 Jan; 37(1):25-9. PubMed ID: 7072303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipidemia and arteriosclerosis obliterans].
    Shindo S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():690-7. PubMed ID: 11351672
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-133a in the Development of Arteriosclerosis Obliterans.
    Ono K
    J Atheroscler Thromb; 2015; 22(4):342-3. PubMed ID: 25740337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydroxyproline excretion in the urine in endangiitis and arteriosclerosis obliterans].
    Emmrich R
    Z Gesamte Inn Med; 1969 Nov; 24(21):747-52. PubMed ID: 5365450
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arteriosclerosis obliterans and Buerger's disease].
    Ishimaru S; Yao Y
    Ryoikibetsu Shokogun Shirizu; 1996; (14):553-6. PubMed ID: 9047930
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on arteriosclerosis and endangitis obliterans. IV. Phosphomonoesterase activity of vascular wall in arteriosclerosis and endangiitis obliterans].
    SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ
    Z Gesamte Exp Med; 1954; 122(6):497-504. PubMed ID: 13170026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arteriosclerosis obliterans of the vessels of the lower extremities].
    Kotel'nikov VP
    Feldsher Akush; 1988 Nov; 53(11):17-22. PubMed ID: 3220132
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correction of dyslipidemia in patients with arteriosclerosis obliterans as a method for improving the results of endovascular angioplasty].
    Petukhov VA; Seitmykhamedov MD; Dibirov AD; Dubovik SG; Sergeeva NA; Prokubovskiĭ VI
    Grud Serdechnososudistaia Khir; 1992; (7-8):33-5. PubMed ID: 1457133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of risk factors in arteriosclerosis obliterans of the lower extremities. Preliminary results].
    Forest JC; Clavel F; Côte J; Guidoin R; Gosselin C
    Union Med Can; 1981 Aug; 110(8):715-9. PubMed ID: 7292803
    [No Abstract]   [Full Text] [Related]  

  • 20. [The arteriosclerotic mask in endangiitis obliterans].
    Garaguly G; Weidinger P; Hagmüller G
    Vasa; 1978; 7(4):452-6. PubMed ID: 726616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.